TIDMPEBI

RNS Number : 2799V

Port Erin Biopharma Investments Ltd

15 April 2016

Port Erin Biopharma Investments Limited

("Port Erin" or the "Company")

Change of Adviser

The Board of Port Erin, the AIM quoted company focused on investing in the biotechnology and biopharmaceutical sectors, is pleased to announce the appointment of Northland Capital Partners Limited as the Company's Nominated Adviser and Joint Broker with immediate effect.

Enquiries

 
 Port Erin Biopharma Investments         +44(0) 1624 
  Limited                                 639396 
 Denham Eke 
 
                                         +44(0) 203 
 Northland Capital Partners Limited       861 6625 
 Nominated Adviser and Joint Broker 
 Matthew Johnson / David Hignell 
  / Gerry Beaney (Corporate Finance) 
 John Howes / Rob Rees (Broking) 
 
                                         +44(0) 207 
 Peterhouse Corporate Finance Limited     469 0936 
 Joint Broker 
 Lucy Williams 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

APPBLGDSBXBBGLS

(END) Dow Jones Newswires

April 15, 2016 02:00 ET (06:00 GMT)

Agronomics (LSE:ANIC)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Agronomics Charts.
Agronomics (LSE:ANIC)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Agronomics Charts.